Oura to Acquire Counsel Health for $625 Million, Putting a Doctor Behind the Ring

Oura, the company behind the Oura Ring, has entered into a definitive agreement to acquire Counsel Health, an AI-native primary care company, for $625 million in cash. Announced on November 10, 2026, the deal moves Oura beyond tracking health into delivering care: the ring's continuous biometric data will be paired with Counsel's medical AI and its network of licensed physicians, who can diagnose, prescribe and order lab tests. The transaction is expected to close before the end of the calendar year, subject to customary closing conditions.

What Happened

Under the terms of the agreement, Oura is acquiring Counsel Health for $625 million in cash, subject to purchase price adjustments. The announcement was made jointly by the two companies on November 10, 2026, and issued via Business Wire.

Counsel Health was founded in 2023 by Dr. Muthu Alagappan, a Stanford-trained physician and former chief medical officer at Notable Health. Counsel pairs a medical AI chatbot with in-house, board-certified physicians, serving health plans, health systems, digital health companies, employers and consumers. Approximately 70 Counsel employees will join Oura following the transaction, and Alagappan will become Oura's chief clinical AI officer. Counsel will continue serving health plans, health systems and employers, including people who are not Oura members.

The deal builds on an existing integration: Counsel's medical assistance has been in the Oura app since June 2026. Oura chief executive Tom Hale said the combination would allow members to act on information about their physiology through services ranging from everyday medical questions to chronic care and referrals.

The deal was announced alongside a record quarter for Oura. For the fiscal fourth quarter ended September 30, 2026, revenue grew 153 percent year over year to $533 million, with $87 million of adjusted EBITDA. For its fiscal year 2026, Oura generated revenue of approximately $1.75 billion, representing 92 percent year-over-year growth, and the company has more than six million members. Those figures are preliminary and unaudited; how Oura will fund the deal was not disclosed.

What Oura and Counsel Do

Oura is a health intelligence platform built around the Oura Ring, a smart ring that tracks more than 50 biometric markers — sleep, activity, heart rate, temperature and recovery — continuously and unobtrusively.

Counsel Health is part of a newer category: AI-native primary care. Its model starts with a conversational medical AI that takes a patient's history and symptoms, then escalates to employed, board-certified physicians. The idea is to collapse the distance between noticing a symptom and getting care — and to do it at a cost structure that traditional clinics cannot match, because the AI handles the routine work and physicians focus on clinical judgement.

Why It Matters

The acquisition is one of the largest pure-play deals in digital health this year, and it signals where the wearables industry is heading. Tracking alone is becoming a commodity: rings, watches and patches all measure roughly the same things, and the hardware margins are under pressure. The value is moving to what happens after the measurement — interpretation, guidance and, now, treatment.

Oura is making a bet that the company which owns both the data and the care relationship wins. A ring that only reports a bad night's sleep is a gadget; a ring connected to a doctor who can act on it is a health service, and health services can charge very differently from gadgets.

Risks are real: delivering care brings regulation, liability and clinical responsibility a hardware company has never carried, and the integration must prove AI triage is safe and physicians genuinely in charge.

What This Means for Founders and Investors

For founders in digital health, the Oura–Counsel deal redraws the map. Wearables, AI triage and virtual care were three separate markets; they are now converging into one, and the companies that own the full loop — sensing, interpretation, care — have a structural advantage over point solutions.

For investors, the transaction is a benchmark for digital health valuations and a test of the "wearable to care" thesis. The questions to watch are the close before year end, whether Counsel's physician service becomes part of the Oura membership or stays a separate add-on, and how the combined company reports its first results. If Oura can show that ring data plus physician care produces better outcomes at lower cost, it will have built something no pure hardware company and no pure telehealth company can easily replicate — and the next wave of health-tech funding will follow that pattern.

Angeled.com connects founders with investors.